Swain, S. 2-Hour 75 Gm OGTT for Screening and Rescreening at 32-34 Weeks for Diagnosing Gestational Diabetes-Evaluation of Maternal and Neonatal Outcomes. Int J Reprod Contracept Obstet Gynecol 2017, 6, 2926-2932.